Brian Gallagher, Jr.

Brian Gallagher, Jr. - Managing Partner and Co-Founder at Trekk Venture Partners

Brian Gallagher, Jr. is the Managing Partner and Co-Founder of Trekk Venture Partners, a venture capital firm dedicated to investing in early stage biotech companies developing life-changing medicines.13 He has over 25 years of investing, business development, operational and R&D experience in both biotechnology and large pharmaceutical companies.12

Key Roles and Investments

• Chairman of the Board at eFFECTOR Therapeutics (NASDAQ: EFTR)1
• Non-executive Director at Slate Bio1
• Partner and Head of the Boston office at Abingworth from 2018-2022, where he led investments in and was on the boards of Q32 Bio and eFFECTOR1
• Partner at SR One, the venture capital arm of GlaxoSmithKline (GSK) from 2010-2018, where he led investments in and was on the boards of numerous biotech companies1
• Led Corporate Development at Sirtris Pharmaceuticals from 2008-2010 where he was responsible for business and corporate development, business operations and post-merger integration following the company's $720M acquisition by GSK in 20081
• Held key roles in operations and R&D at Alantos Pharmaceuticals from 2005 until its acquisition by Amgen for $300M in 20071

Education and Background

• PhD and MS degrees in Organic Chemistry from the University of Michigan1
• BS in Chemistry from the University of Massachusetts, where he was a Shapiro scholar1
• Inventor on over 25 patents and applications and is the senior author of a number of publications in prominent journals1
• Serves on the Investment Board for University of Michigan Biomedical Venture Fund (MBVF) and the Advisory Board for Michigan Drug Discovery1